Search dm+d | This VMP cannot be matched against our prescribing data.
Name | Reteplase 10unit powder and solvent for solution for injection vials |
BNF code | 0210020K0AAAAAA |
Virtual Therapeutic Moiety | Reteplase |
Date identifier became valid | 22 Oct 2018 |
Previous product identifier | 319845001 |
Abbreviated name | Reteplase 10unit inj vials |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 9 Jun 2004 |
Previous name | Reteplase 10unit injection vials and diluent |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Non-availability | Actual Products not Available |
Non-availability status date | 4 Mar 2016 |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | vial |
Unit dose unit of measure | vial |
Virtual Product Ingredient | |
---|---|
Ingredient | Reteplase |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 10.000 |
Strength value numerator unit | unit |
Ontology Drug Form & Route | |
Form & Route | solutioninjection.intravenous |
Dose Form | |
Formulation | Powder and solvent for solution for injection |
Drug Route | |
Route | Intravenous |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Virtual Medicinal Product Packs | |
Reteplase 10unit powder and solvent for solution for injection vials 2 vial |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.